Heeyoung Kim has over 17 years of experience in the clinical industry, contributing significantly to advancements in drug development. As a trusted advisor, her career reflects a commitment to enhancing the drug development lifecycle through innovative solutions and effective communication of industry trends. Her primary focus is identifying gaps between the current state and the industry’s goals, then finding solutions to achieve unmet targets. She influences market stakeholders to better understand new global trends and regulatory updates. Looking ahead, Heeyoung aims to continue improving drug development processes by introducing new technical insights and methodologies to advance the industry.